![Brian Tinmouth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Tinmouth
Direktor/Vorstandsmitglied bei
SCYNEXIS, INC.
Vermögen: 49 349 $ am 30.06.2026
Profil
Brian Philippe Tinmouth is currently an Independent Director at SCYNEXIS, Inc. since 2019.
Formerly, Mr. Tinmouth was Chief Business & Strategy Officer at Mammoth Biosciences, Inc. from 2022 to 2025, Chief Business & Strategy Officer at Pardes Biosciences, Inc. from 2021 to 2022, Vice President & Head-Business Development at Vertex Pharmaceuticals, Inc. from 2013 to 2020, and Senior Manager at Bain & Co., Inc. from 1997 to 2002.
Mr. Tinmouth completed undergraduate studies at Queen's University and earned an MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SCYNEXIS, INC. 0.12% | 26.06.2026 | 12’125 ( 0.12% ) | 49 349 $ | 30.06.2026 |
Aktive Positionen von Brian Tinmouth
| Unternehmen | Position | Beginn |
|---|---|---|
| SCYNEXIS, INC. | Direktor/Vorstandsmitglied | 13.12.2019 |
Ehemalige bekannte Positionen von Brian Tinmouth
| Unternehmen | Position | Ende |
|---|---|---|
Mammoth Biosciences, Inc.
 Mammoth Biosciences, Inc. Internet Software/ServicesTechnology Services Operates CRISPR-based platform for disease detection | Corporate Officer/Principal | 01.02.2025 |
| PARDES BIOSCIENCES, INC. | Corporate Officer/Principal | 30.11.2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.03.2020 |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing, organization, operations, IT and M&A consulting services | Corporate Officer/Principal | 01.01.2002 |
Ausbildung von Brian Tinmouth
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing, organization, operations, IT and M&A consulting services | Commercial Services |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mammoth Biosciences, Inc.
Mammoth Biosciences, Inc. Internet Software/ServicesTechnology Services Operates CRISPR-based platform for disease detection | Technology Services |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
Wählen Sie MarketScreener 
